This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Gary Heimberg Joins Covington's Global Public Policy Group

June 2, 2015

WASHINGTON, DC, June 2, 2015 - Gary Heimberg has joined Covington’s global public policy and government affairs group in the firm’s Washington office. Mr. Heimberg will advise the firm’s pharmaceutical and consumer health care clients on legislative and policy issues facing the pharmaceutical industry, including in the areas of intellectual property, over-the-counter medicines, vaccines, medical devices, biodefense, and Food and Drug Administration reform.

“Gary will be a tremendous asset to the firm and our clients,” said Dan Bryant, chair of Covington’s public policy and government affairs practice. “His extensive policy and legislative experience across all the life sciences issues will be invaluable as we work with clients to address the multiple legislative initiatives affecting the life sciences industry now pending in Congress.”

Mr. Heimberg has previous experience in government, private practice and the pharmaceutical industry. Most recently, he served as the director for federal government relations at GlaxoSmithKline, the multinational pharmaceutical company. Earlier in his career, Mr. Heimberg spent 14 years as a lawyer with an international firm in Washington. He also spent more than two years as a professional staff member for the U.S. Senate Committee on Labor and Human Resources.
 
“I am thrilled to join one of the most respected public policy teams in the nation, and to help Covington’s clients navigate and shape global policy developments,” Mr. Heimberg said.

Mr. Heimberg received a bachelor’s degree, a master’s degree and a law degree from George Washington University. 
 

Share this article: